Literature DB >> 22773188

Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?

Maurizio Muscaritoli1, Simone Lucia, Alessio Molfino, Tommy Cederholm, Filippo Rossi Fanelli.   

Abstract

Cachexia and sarcopenia present several analogies in both the pathogenic mechanisms and the clinical picture. The loss of muscle mass and strength is a hallmark of these two clinical conditions. Although frequently overlapping and often indistinguishable, especially in old individuals, these two conditions should be considered distinct clinical entities. A prompt and accurate patient evaluation, guiding the physician through a proper differential diagnostic procedure and providing the best therapeutic options, is recommended. Given the several commonalities between cachexia and sarcopenia, it is likely that the therapeutic approaches may prove effective in both conditions. This review focuses on the most recent available literature and aims at providing physicians with the correct tools that are available to aid in diagnosing these two different entities that often clinically overlap. Currently available or proposed therapeutic strategies for pre-cachexia, cachexia and sarcopenia are also briefly described.

Entities:  

Mesh:

Year:  2012        PMID: 22773188     DOI: 10.1007/s11739-012-0807-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  72 in total

Review 1.  Microgravity as a model of ageing.

Authors:  Gianni Biolo; Martina Heer; Marco Narici; Felice Strollo
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2003-01       Impact factor: 4.294

Review 2.  Optimal protein intake in the elderly.

Authors:  Robert R Wolfe; Sharon L Miller; Kevin B Miller
Journal:  Clin Nutr       Date:  2008-09-25       Impact factor: 7.324

3.  Body composition and mortality in chronic obstructive pulmonary disease.

Authors:  Annemie M W J Schols; Roelinka Broekhuizen; Clarie A Weling-Scheepers; Emiel F Wouters
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 5.  Sarcopenia: characteristics, mechanisms and functional significance.

Authors:  Marco V Narici; Nicola Maffulli
Journal:  Br Med Bull       Date:  2010-03-02       Impact factor: 4.291

6.  Association between muscle strength and metabolic syndrome in older Korean men and women: the Korean Longitudinal Study on Health and Aging.

Authors:  Eun Joo Yang; Soo Lim; Jae-Young Lim; Ki Woong Kim; Hak Chul Jang; Nam-Jong Paik
Journal:  Metabolism       Date:  2011-08-25       Impact factor: 8.694

7.  Cachexia as a major underestimated and unmet medical need: facts and numbers.

Authors:  Stephan von Haehling; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

8.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

9.  The 'cancer cachectic factor'.

Authors:  Michael J Tisdale
Journal:  Support Care Cancer       Date:  2002-11-05       Impact factor: 3.603

Review 10.  Inflammatory markers and cardiovascular risk in the metabolic syndrome.

Authors:  Christine Espinola-Klein; Tommaso Gori; Stefan Blankenberg; Thomas Munzel
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01
View more
  23 in total

1.  Muscle depletion and the prediction of chemotherapy toxicity.

Authors:  Maurizio Muscaritoli; Alessio Molfino; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2013-06-11       Impact factor: 3.397

2.  Cortisol and the muscle-bone axis.

Authors:  A Molfino; Z Aversa; M Muscaritoli
Journal:  Osteoporos Int       Date:  2014-07-08       Impact factor: 4.507

Review 3.  The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.

Authors:  Hánah N Rier; Agnes Jager; Stefan Sleijfer; Andrea B Maier; Mark-David Levin
Journal:  Oncologist       Date:  2016-07-13

Review 4.  Dysregulation of skeletal muscle protein metabolism by alcohol.

Authors:  Jennifer L Steiner; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-03-10       Impact factor: 4.310

Review 5.  Epidemiology of sarcopenia and insight into possible therapeutic targets.

Authors:  Elaine M Dennison; Avan A Sayer; Cyrus Cooper
Journal:  Nat Rev Rheumatol       Date:  2017-05-04       Impact factor: 20.543

6.  Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.

Authors:  Jordan Blondelle; Kavya Tallapaka; Jane T Seto; Majid Ghassemian; Madison Clark; Jenni M Laitila; Adam Bournazos; Jeffrey D Singer; Stephan Lange
Journal:  JCI Insight       Date:  2019-04-16

7.  Novel TAZ modulators enhance myogenic differentiation and muscle regeneration.

Authors:  Gun Hwa Park; Hana Jeong; Mi-Gyeong Jeong; Eun Jung Jang; Myung Ae Bae; Ye-Lim Lee; Nak Jung Kim; Jeong-Ho Hong; Eun Sook Hwang
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

8.  Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study.

Authors:  Chiara Maddalena; Andrea Ponsiglione; Luigi Camera; Lidia Santarpia; Fabrizio Pasanisi; Dario Bruzzese; Camilla Panico; Giovanni Fiore; Simona Camardella; Tolomeo Caramia; Alessia Farinaro; Sabino De Placido; Chiara Carlomagno
Journal:  World J Clin Oncol       Date:  2021-05-24

9.  Development and relative validity of a new field instrument for detection of geriatric cachexia: preliminary analysis in hip fracture patients.

Authors:  Anthony M Villani; Michelle D Miller; Ian D Cameron; Susan Kurrle; Craig Whitehead; Maria Crotty
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-05-18       Impact factor: 12.910

Review 10.  Development and decline of upright gait stability.

Authors:  Marco Iosa; Augusto Fusco; Giovanni Morone; Stefano Paolucci
Journal:  Front Aging Neurosci       Date:  2014-02-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.